The pharmaceutical tablet coating landscape in 2026 is no longer purely about aesthetics or stability. It is a patient-facing technology that directly influences swallowability, compliance, and even consumer trust
In this blog, we have compiled the key pharma coating trends shaping 2026 and how they are redefining modern drug formulation.
Tablet Coating Trends in 2026
As oral solid dosage (OSD) formulations are being reimagined around four major shifts:
- Advanced polymer science
- Clean-label and TiO₂-free formulations
- Patient-centricity
- Manufacturing efficiency
Let us understand each of these in detail.
- Patient centricity:
- Easy to swallow coating:
Easy to swallow coatings represent one of the fastest-growing segments within functional film coating. They reduce the coefficient of friction at the tablet surface. This enables smooth transit through the oropharynx and esophagus, without interfering with the tablet’s barrier and release properties.
Novo Excipients Novomix ES is a purpose-engineered easy-swallow film coating system. This film coating is a blend of hydroxypropyl methylcellulose (HPMC) and slip-enhancing agents. This results in a tablet that patients describe as sliding easily, a perception that directly influences willingness to take subsequent doses.
Odor masking coating:
An unpleasant smell from a film-coated tablet can be enough to discourage a patient from taking their next dose. Many APIs have intrinsically strong or disagreeable odors. Common examples of such APIs are omega-3 fatty acids, certain antimicrobials, B-vitamins, herbal extracts, and sulfur-containing compounds. Without an effective odor barrier, patients often avoid consuming the medicine.
Novo Excipients addresses this with Novomix OM, its dedicated odour masking film coating system. Formulated using a dual-polymer matrix of HPMC and Acrylic Polymers, Novomix OM creates a low-permeability film barrier that physically limits vapor-phase transmission of volatile odor compounds.
- Clean formulation – TiO₂-free coating: The concept of “clean label” is well established in food science and has now entered the pharmaceutical formulations. Patients, pharmacists, and increasingly regulators are scrutinizing excipient lists, especially for TiO₂. The European Medicines Agency’s ongoing review of titanium dioxide (TiO₂) use in medicines has moved TiO₂-free formulations from a future-proofing exercise to an active development priority.
Novo Excipients has addressed this directly with Novomix TF, a specialized, titanium dioxide free film coating system. All ingredients used in Novomix TF are in accordance with current pharmacopoeial and regulatory requirements.
- Advanced Polymer Science and Smarter Formulation:
In 2026, polymers are active performance enablers. Advanced polymer systems improve drug release, enhance solubility, protects moisture-sensitive APIs and create sustained-release systems. This, in turn, improves patient compliance.
Novo’s NOVOSERIES portfolio aligns closely with these evolving formulations. For example, HPMC-based tablet coating with NOVOCOAT supports immediate-release formulations and sustained-release systems.
NOVODONE (PVP) and NOVODONE VA (Copovidone) enhance dissolution and improve bioavailability. NOVODONE CR (Crospovidone) supports fast-disintegrating chewable and pediatric formulations.
As pharmaceutical formulations become more complex and patient-centric, advanced polymer systems are becoming essential for balancing performance, process efficiency, and patient compliance.
- Coating for manufacturing efficiency:
Continuous manufacturing is reshaping pharmaceutical production workflows, including pharma tablet coating operations. To adhere to continuous manufacturing, there is a need for coatings that cut coating cycle time. A shorter coating cycle means less cumulative moisture exposure for a hygroscopic core, fewer thermal stress cycles on a heat-sensitive API, and lower per-unit production cost. All these factors affect the end quality of film coated tablets.
Novomix FAST operates at 25% aqueous solids and is documented to reduce coating process time by up to 50% compared to standard coating systems. Our latest launch, Novomix Teez, is the most advanced, globally first ever innovative, multifunctional aqueous ready-mix film coating system. It is a fully water based coating system, with 40% solids capability. This unique coating system makes your coating process superfast, while saving time and energy.
The Future of Pharma Tablet Coating:
The coating trends that define 2026 share a single underlying principle: the coating material of tablets is no longer an afterthought. It is patient-facing technology. The coatings of 2026 are expected to deliver functionality beyond protection. They are expected to support complex drug delivery, align with clean-label expectations, and improve treatment adherence.
Conclusion:
With increasing patient expectations and formulation challenges, the coating industry’s focus will continue shifting toward smarter, cleaner, and more patient-friendly tablet coating systems.
Novo Excipients, with over 40 years of experience as a tablet coating manufacturer, has a portfolio of products that support both pharmaceutical performance and patient-centric drug delivery.
Connect with the NovoExcipients team to experience advanced film coating systems.